Miguel Rios is the founder of Endeavor BioMedicines. Endeavor BioMedicines has raised $292M in total funding. Latest round: Series A.
Miguel de los Rios is a Founder, President, and Chief Scientific Officer at Endeavor BioMedicines, a clinical-stage biotechnology company. The company focuses on developing medicines for life-threatening diseases, particularly pulmonary fibrosis and other serious conditions.
Full founder directory · Investor directory · Company funding database · Fundraising library